Management of Flank Folliculitis in Testosterone Replacement Therapy
Treat the folliculitis with standard topical or oral antibiotics while continuing testosterone therapy at a reduced dose, and consider switching to a different testosterone formulation if the current one is causing local skin reactions.
Understanding the Connection
Folliculitis is a recognized dermatologic adverse effect of testosterone replacement therapy (TRT). Acne and folliculitis occur in 0.6%-9.1% of patients on TRT, with injectable formulations associated with higher rates than topical or oral preparations 1. The Endocrine Society guidelines specifically identify formulation-specific adverse effects, including skin reactions at application sites for patches and local reactions (pain, soreness, erythema, swelling, nodules, or furuncles) for intramuscular injections 2, 3.
Management Algorithm
Step 1: Assess Severity and Location
- Document the extent and distribution of folliculitis on the flanks
- Determine if this is related to application site (for transdermal products) or systemic androgen effect
- Rule out other causes: bacterial folliculitis, fungal infection, or mechanical irritation
Step 2: Treat the Folliculitis Directly
- For mild cases: Topical antibiotics (clindamycin) or benzoyl peroxide
- For moderate-to-severe cases: Oral antibiotics (doxycycline or minocycline)
- For refractory cases: Consider oral isotretinoin, which has shown 90% stable remission rates in severe follicular conditions 4
Step 3: Modify Testosterone Therapy
Do not discontinue testosterone if clinically indicated, but optimize the regimen:
- If using transdermal patches: Switch to gel or injectable formulation, as patches cause skin reactions in up to 66% of users versus 5% with gels 3
- If using injectable testosterone: Consider reducing dose or switching to more frequent, smaller injections (50-100 mg weekly instead of 200-300 mg every 2-3 weeks) to minimize peak testosterone levels that may exacerbate folliculitis 2
- If using gel: Ensure proper application technique and consider oral testosterone undecanoate (if available) which has the lowest acne incidence 1
Step 4: Monitor Testosterone Levels
Measure serum testosterone 2-3 months after any formulation change:
- Target mid-normal range (450-600 ng/dL)
- For injectable testosterone enanthate/cypionate: measure midway between injections
- For transdermal gel: measure anytime after 1 week of use
- Adjust dose to maintain therapeutic levels while minimizing androgenic skin effects 2, 5
Critical Monitoring Points
The Endocrine Society guidelines mandate evaluation at 3 months after treatment initiation and annually thereafter to assess adverse effects 2. At each visit, specifically evaluate formulation-specific adverse effects, including examination of skin at application sites or injection sites 5.
Common Pitfalls to Avoid
- Do not stop testosterone abruptly in symptomatic hypogonadal men, as this will worsen their underlying condition without necessarily resolving the folliculitis immediately
- Do not assume all folliculitis is infectious - androgenic folliculitis may not respond to antibiotics alone and requires formulation adjustment 6
- Do not ignore patient preference - adherence improves when formulation matches lifestyle, so involve the patient in choosing an alternative delivery method
- Do not overlook exacerbating factors - long-term testosterone use may predispose to follicular occlusion disorders, particularly with repeated skin trauma 7
Special Considerations
If folliculitis persists despite formulation changes and standard treatments, consider:
- Dermatology referral for trichoscopy and possible biopsy to rule out dissecting cellulitis or other follicular occlusion disorders 7
- Temporary dose reduction (while maintaining therapeutic benefit) until skin clears
- In severe refractory cases, oral isotretinoin under dermatologic supervision 4
The goal is to maintain the benefits of testosterone therapy (improved sexual function, body composition, bone density, and quality of life) 8 while managing the dermatologic side effect through formulation optimization and targeted skin treatment.